Press Releases
- February 26, 2008
Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
- December 18, 2007
Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
- December 17, 2007
Ambrx Announces Drug Discovery Alliance with Eli Lilly and Company
- July 24, 2007
Ambrx Appoints Stephen Kaldor Chief Executive Officer
- June 19, 2007
Merck Serono and Ambrx to Collaborate on Development of Next Generation Growth Hormone Products
- February 12, 2007
Ambrx Initiates Phase I/II Clinical Trial of Novel Human Growth Hormone Product Candidate
- August 14, 2006
Ambrx Receives Additional U.S. Patent Covering ReCODE™ Technology
- July 24, 2006
Ambrx Secures Additional $3 Million in Series C Financing
- July 19, 2006
Ambrx Names Kevin L. Eastwood Vice President, Corporate Development
- July 05, 2006
Ambrx Secures $52 Million in Series C Financing
- May 23, 2006
Ambrx Receives Broad U.S. Patent Covering In Vivo Incorporation of Unnatural Amino Acids
- May 23, 2006
Ambrx Names Hazel M. Aker Senior Vice President, Operations and Business Affairs
- January 10, 2006
Ambrx to Present at the 24th Annual JPMorgan Healthcare Conference
- December 08, 2005
Ambrx and Roche Enter into Broad Technology Collaboration
- September 20, 2005
Ambrx Appoints Martin A. Mattingly as President and CEO
- June 21, 2005
FierceBiotech Announces Third Annual List of "Fierce 15" Companies of 2005
- June 03, 2005
CMC Biopharmaceuticals A/S and Ambrx, Inc. announce development and manufacturing agreement
- April 13, 2005
Ambrx Appoints Dr. August Watanabe to Board of Directors
- April 08, 2005
Ambrx Completes $23.4 Million Private Placement
- April 06, 2005
Ambrx Appoints Bruce Kimmel, Ph.D. as Vice President, Therapeutic Applications
- March 02, 2004
Ambrx Adds to Senior Management Team with the Appointment of John Wallen as Vice President, Intellectual Property
- September 22, 2003
Ambrx Assembles World Class Team and Raises $12.5 Million to Apply Breakthrough
Articles
- April 1, 2005
Unnatural Amino Acid Could Prove Boon for Protein Therapeutics
Science Magazine - March 14, 2005
Giving Biotechnology A Chemical Push
Chemical & Engineering News - March 14, 2005
Watching Peptide Drugs Grow Up
Chemical & Engineering News - January 12, 2004
The Code Breakers
Bio-IT World - October 6, 2003
Executive Profile - RICHARD D. DIMARCHI
SD Business Journal (paid access) - September 29, 2003
Ambrx Inc. Lands $12.5M in First-Round Funding
SD Business Journal (paid access) - September 23, 2003
First-Round Financing of $12.5M Puts Ambrx On Development Path
BioWorld Today - September 22, 2003
Schultz seeks another success with Ambrx
The Daily Deal
